1 / 21

BRIEFING ON GENETICALLY MODIFIED ORGANISMS

BRIEFING ON GENETICALLY MODIFIED ORGANISMS. Acting director general: mr peter thabete Department of agriculture, fisheries and forestry. OUTLINE OF BRIEFING. 1. BACKGROUND INFORMATION ON BIOTECHNOLOGY/ GENETICALLY MODIFIED ORGANISMS (GMOs)

wpratt
Download Presentation

BRIEFING ON GENETICALLY MODIFIED ORGANISMS

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. BRIEFING ON GENETICALLY MODIFIED ORGANISMS Acting director general: mr peter thabete Department of agriculture, fisheries and forestry

  2. OUTLINE OF BRIEFING 1. BACKGROUND INFORMATION ON BIOTECHNOLOGY/ GENETICALLY MODIFIED ORGANISMS (GMOs) 2. LEGISLATION: GENETICALLY MODIFIED ORGANISMS ACT, 1997 (ACT NO. 15 OF 1997) AND AMENDMENTS 3. STATUS OF GM CROP ADOPTION IN SOUTH AFRICA 4. STATUS REGARDING TRANSBOUNDARY MOVEMENT OF GMOS

  3. 1... BIOTECHNOLOGY/ GMOs Defining Biotechnology A “toolbox” of various techniques that uses living organisms or derivatives thereof to modify or make useful products. In the past this has included selective breeding for improvement of plants and animals and the fermentation of commodities such as bread, beer, wine, cheese etc Defining Modern Biotechnology Discovery of genetic code or “DNA” biotechnology applications were able to facilitate the transfer of genetic material within and beyond the species boundaries thus allowing living organisms to be modified or altered at a genetic level, resulting in what is known as a genetically modified organism (GMO). Collectively this process is termed genetic engineering/ modification and represents but one of the many tools in the biotechnology “toolbox”.

  4. 1…BIOTECHNOLOGY POLICY CONTEXT National Biotechnology Strategy (2001) Promotes the establishment of a thriving biotechnology sector through various interventions because of potential to contribute to economic development. Biotechnology Opportunities increase agricultural production in a sustainable manner address production challenges relating to limited arable land and the declining natural resource base. Nutritionally enhanced food CAUTION! GM technology not solution to every problem but instead should be considered in combination with other sustainable technologies and existing agricultural practices

  5. 2. LEGISLATION: GENETICALLY MODIFIED ORGANISMS ACT, 1997 (ACT NO. 15 OF 1997) AND AMENDMENTS

  6. 2…GMOS: SA REGULATORY LANDSCAPE Department of Agriculture, Forestry & Fisheries Department of Science & Technology Department of Environmental Affairs Department of Trade and Industry Department of Health National Biotechnology Strategy 2001 GMO Act, 1997 (Amendment in 2006) National Environmental Management Act, 1998 Foodstuffs, Cosmetics, and Disinfectants Act, 1972 Consumer Protection Act, 2008 Cartagena Protocol for Biosafety-2003 *Competent Authority National Environmental Biodiversity Act, 2004 CODEX Alimentarius Contact Point Convention on Biological Diversity/ Cartagena Protocol *Focal Point

  7. 2...GMO ACT, 1997 • Implemented in 1999 - Ensure activities relating to GMOs are carried out RESPONSIBLY  Limit adverse impact on environment, human/animal health How is this achieved? • Administrative & consultative system • Manage import, export, production, release & distribution • Lay down criteria for risk assessment & risk management • Ensure effective management of waste • Prevent accidents

  8. 2...GMO ACT: REGULATORY INSTRUMENT Act makes provision for the Minister to appoint members to regulatory bodies which exercise oversight over the safety assessment and approval of GMO applications. Registrar (Administration) • Environmental Safety • Food & feed safety • Non safety issues e.g. • trade & • socio-economics Advisory Committee Technical experts responsible for safety assessment Executive Council Decision makers represented by DAFF, DEA, DoH, the dti, DoL, DST & AC Chair

  9. 2...International Obligations: Cartagena Protocol on Biosafety Cartagena Protocol on Biosafety is an international agreement established under the Convention on Biological Diversity Objective: contribute to ensuring an adequate level of protection for the safe transfer, handling and use of GMOs to limit adverse effects on conservation and biodiversity, also taking into account risks to human health. SA acceded to the Protocol in 2003 Obligations as a Contracting Party to provide legal, administrative and other measures to implement provisions of Protocol DAFF is the recognized Competent Authority and DEA is the Focal Point

  10. 2...GMO Amendment Act (Act 23 of 2006) • Process of amending the Act was initiated in 2003 after SA’s accession to the Cartagena Protocol on Biosafety • Amendments focused on alignment with provisions of Protocol and related environmental legislation • GMO Amendment Bill subjected to parliamentary processes and was approved by President in April 2007. • In 2008 regulations were drafted and gazetted for public input. • Following review and consultation of comments, regulations were finalized and submitted for approval in 2009. • In February 2010 Amendment Act was proclaimed and the regulations gazetted for implementation.

  11. 2...GMO Amendment Act (Act 23 of 2006) Status of implementing key amendments to the Act: • Procedures already in place to address transboundary movement of GMOs in compliance with Protocol • Protocol provisions for risk assessment and risk management already implemented • Consultation with related government departments on environmental and socioeconomic impact assessments is ongoing • Development of official biosafety clearing house is near completion • Administrative processes initiated to facilitate inclusion of representation on EC from Arts and Culture, Water Affairs and Forestry

  12. 3. STATUS OF GM CROP ADOPTION IN SOUTH AFRICA

  13. 3. STATUS OF GM CROP ADOPTION IN SA SA AREA PLANTED WITH GM CROPS Total Maize = 78% of total maize ha White maize: hectares, 64% crop Yellow maize: hectares, % crop Soybean: 85% crop Cotton: 92-95% crop Total Area : 2,1 million hectares (ISAAA, 2009) GM Crops – Commercially Approved

  14. (Source: ISAAA 2009)

  15. 3....IMPACT OF GM CROPS Economic benefits Less crop damage due to effective insect control Improved yields Reduced chemical use Savings on input costs Increased farm income Potential benefits for both small scale and commercial producers Cumulative benefits from 1999-2009 estimated at $500 mill for SA (ISAAA, 2009) BT Maize: BT Cotton: Source: Gouse et al (2003, 2004, 2005)

  16. 4. STATUS REGARDING TRANSBOUNDARY MOVEMENT OF GMOS

  17. 4. STATUS REGARDING TRANSBOUNDARY MOVEMENT OF GMOS Imports/ Exports procedures applicable to: GM seed for intentional introduction into the environment i.e. For planting GM Commodity for direct use as food, feed or processing (not planting) Procedures strictly comply with Protocol requirements (Articles 7,8,11 & 18) Generally follows a process involving- Notification of GM events in the consignment Decision making based on available risk assessment data of GM events Communication of decision and issuance of relevant authorisation documents if appropriate. Challenges where contracting Parties to the Protocol are at different levels of implementation and do not yet have all the required procedures in place.

  18. 4. ...STATUS OF GM COMMODITY IMPORTS In 2005, Executive Council (EC) suspended all existing and new applications for commodity imports of GM maize. Decision based on the dti’s concerns regarding the possible negative impact of GM commodity trading on local producers. To facilitate decision making a study was commissioned by the EC to investigate the issues raised by the dti. Outcomes of the study broadly confirmed that restricting access to new GM maize events would disadvantage both domestic producers and consumers of GM maize.

  19. 4. ..STATUS OF GM COMMODITY IMPORTS (cont.) Following an analysis of the study report the dti recommended to the EC that: Imports of GM maize commodity be allowed only if DAFF is able to ensure adequate control measures for policing and monitoring of commodity imports. Import of GM sugarcane not be allowed unless verification is possible through scientific testing. Consultation with SACU member states on the development of regulatory measures for GM commodities due to potential risks of transboundary movement of GM products to SACU countries. In response to the dti’s recommendations the EC has commissioned several interventions to address strengthening of regulatory control measures. Since EC decisions are consensus based, the Council is currently awaiting the final position by the dti on whether they are satisfied that their concerns have been addressed.

  20. 4. ..GM COMMODITY EXPORTS Same consideration given to SA for commodity imports needs to be extended to importing Parties when SA is the exporting country. GM maize exports to Kenya: Both Kenya and SA are Parties to the Protocol GM status of maize consignment was declared to Kenya Import authorisation was issued by Kenya accepting the consignment Export permit issued by SA for mixed consignment of GM maize to Kenya for use as a commodity (i.e. not for planting) Follow ups with Kenyan government regarding status of maize consignment resulted in response from KEPHIS that shipment of maize was transferred to a warehouse. No official communication received since media reports.

  21. CONCLUDING REMARKS To date SA has made significant progress with the alignment and implementation of its Biosafety Regulatory Framework Because the regulatory framework in SA cannot function within a vacuum we have to take cognizance of Agreements and Protocols that apply at an International level in the interest of ensuring our trade credibility for accessing international markets. We do acknowledge the challenges relating to GMOs in so far as different countries expressing different viewpoints on the subject and being at different levels of regulatory implementation. Continue to engage our regulatory counterparts on technical issues relating to GMOs in an attempt to address some of the identified challenges.

More Related